Aerovate Therapeutics (AVTE) Q4 2024 Earnings

Nov 12Confirmed
Q4 2023
Q2 2024
Q3 2024
Q4 2024
-0.86
-0.73
-0.6
-0.47

Details

Expected EPS
-0.467467
Actual EPS
-0.56
Surprise EPS
-0.09
Surprise Percent
-19.79%

Description

⁨Aerovate Therapeutics⁩ (⁦AVTE⁩) has reported earnings of ⁦-0.56⁩ per share for ⁦Q4 2024⁩.

0 Comments

Share your thoughts